Hester Biosciences Ltd reports Net Profit of Rs. 3.56 crore and Revenues from Operations of Rs. 50.7 crore in Q1FY23
Mr. Rajiv Gandhi, CEO & MD, Hester Biosciences LtdAugust 10: One of India’s leading poultry and animal vaccine manufacturing companies, Hester Biosciences Limited, has reported a consolidated net profit of Rs. 3.56 crore and Revenue from Operations of Rs. 50.70 crores for the Q1FY23. Individually, the gross margins of the vaccines and the health products have been in line with the corresponding quarter; however, the overall margins have reduced due to the increase in the proportion of health products sales which have lower gross margins compared to vaccines. Health Products sales constituted 34% of the total sales in Q1 FY23, versus 20% in Q1 FY22.Hester Tanzania recently received regulatory approvals for four products, with two additional products under approval. Hester Tanzania h...